Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|5|9|805-824

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.5, Iss.9, 2005-01, pp. : 805-824

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791

By Adis International Limited  

Drugs in R&D, Vol. 8, Iss. 2, 2007-01 ,pp. : 113-119

Adis International

Access to resources Recommend Favorite

A novel CXCR4 antagonist for hematopoietic stem cell mobilization

By Fricker Simon P  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1749-1760

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of CXCR4 antagonists in the treatment of HIV

By Fujii Nobutaka   Nakashima Hideki   Tamamura Hirokazu  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 185-195

Informa Healthcare

Access to resources Recommend Favorite

AMD 3100 induces rapid mobilisation of CD34+ cells

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1504-1514

Bentham Science Publishers

Access to resources Recommend Favorite